FCI
JAZZ icon

Financial Counselors Inc’s Jazz Pharmaceuticals JAZZ Stock Holding History

Financial Counselors Inc’s Portfolio JAZZ Stock Details JAZZ Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-2,376
Closed -$286K – 573
2024
Q1 		$286K Buy
2,376
+522
+28% +$63.9K ﹤0.01% 506
2023
Q4 		$228K Buy
1,854
+45
+2% +$5.62K ﹤0.01% 533
2023
Q3 		$234K Buy
1,809
+33
+2% +$4.4K ﹤0.01% 511
2023
Q2 		$220K Sell
1,776
-58
-3% -$7.8K ﹤0.01% 477
2023
Q1 		$268K Buy
1,834
+16
+0.9% +$2.37K 0.01% 443
2022
Q4 		$290K Hold
1,818
– – 0.01% 437
2022
Q3 		$242K Buy
+1,818
New +$276K 0.01% 439
2016
Q2 		$236K Sell
1,671
-25
-1% -$3.69K 0.01% 392
2016
Q1 		$221K Sell
1,696
-76
-4% -$9.46K 0.01% 397
2015
Q4 		$249K Sell
1,772
-7,421
-81% -$1.03M 0.02% 383
2015
Q3 		$1.22M Sell
9,193
-5,461
-37% -$940K 0.08% 227
2015
Q2 		$2.58M Buy
14,654
+1,683
+13% +$302K 0.16% 171
2015
Q1 		$2.24M Buy
12,971
+1,865
+17% +$320K 0.14% 188
2014
Q4 		$1.82M Buy
+11,106
New +$1.84M 0.12% 207

Other funds holding JAZZ

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
LSV Asset Management
LSV Asset Management Chicago, Illinois $46.4B AUM 27.74% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Pacer Advisors
Pacer Advisors Malvern, Pennsylvania $35.6B AUM 18.19% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
VPC
Vestal Point Capital New York $3.58B AUM 189.12% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
PCM
Polaris Capital Management Boston, Massachusetts $1.22B AUM 26.01% 1-Year Est. Return

Financial Counselors Inc's JAZZ Position: Q2 2024 in Review

Financial Counselors Inc sold out of Jazz Pharmaceuticals (JAZZ) in Q2 2024, closing a stake of 2,376 shares — an estimated $286K sold.

Financial Counselors Inc first reported a position in JAZZ in Q4 2014 and held it in 14 quarters. The position peaked at $2.58M in Q2 2015. 455 funds tracked by Wall St. Rank hold JAZZ as of Q2 2024.

  • Financial Counselors Inc reported no remaining Jazz Pharmaceuticals position as of Q2 2024 after selling out during the quarter.
  • Financial Counselors Inc sold 2,376 Jazz Pharmaceuticals shares in Q2 2024, an estimated $286K.
  • Financial Counselors Inc first reported a position in Jazz Pharmaceuticals in Q4 2014 and held it in 14 quarters.
  • Financial Counselors Inc's Jazz Pharmaceuticals position peaked at $2.58M in Q2 2015.
  • 455 funds tracked by Wall St. Rank held Jazz Pharmaceuticals as of Q2 2024.

Based on Financial Counselors Inc's 13F filing for Q2 2024, filed 1 Aug 2024.